A case of "refractory" lupus erythematosus profundus responsive to rituximab [case report]

Clinical Rheumatology

Volumn 28, Issue 6, 2009, Pages 745-746

  McArdle, Adrian ^a   Baker, Joshua F ^b  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Lupus erythematosus profundus; Refractory; Rituximab

Indexed keywords

CYCLOPHOSPHAMIDE; ETIRACETAM; HYDROXYCHLOROQUINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB; STEROID;

ADULT; AFRICAN AMERICAN; ARTICLE; B LYMPHOCYTE; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; DRUG EFFICACY; DRUG INFUSION; DRUG MEGADOSE; DRUG RESPONSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE DEPLETION; MONOTHERAPY; NAUSEA AND VOMITING; PRIORITY JOURNAL; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; VASCULITIS;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; FEMALE; HUMANS; PANNICULITIS, LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

EID: 67349118765     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1158-3     Document Type: Article

References (6)

1. Martens PB, Moder KG, Ahmed I (1999) Lupus panniculitis: Clinical perspectives from a case series. J Rheumatol 26:68-72
2. Peters MS, Su WPD (1989) Lupus erythematosus panniculitis. Med Clin North Am 73:1113-25
3. Fraga J, García-Díez A (2008) Lupus erythematosus panniculitis. Dermatol Clin 26(4):453-63, vi
4. Ujiie H, Shimizu T, Ito M et al (2006) Lupus erythematosus profundus successfully treated with dapsone: Review of the literature. Arch Dermatol 142:399-401
5. Ordi-Ros J, Cortés F, Cucurull E et al (2000) Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy. J Rheumatol 27(6):1429-33
6. Callen JP (2005) Management of "refractory" skin disease in patients with lupus erythematosus. Best Pract Res Clin Rheumatol 19(5):767-84